182 related articles for article (PubMed ID: 21269261)
21. Protein kinase CK2 impact on intracellular calcium homeostasis in prostate cancer.
Afzal M; Kren BT; Naveed AK; Trembley JH; Ahmed K
Mol Cell Biochem; 2020 Jul; 470(1-2):131-143. PubMed ID: 32436081
[TBL] [Abstract][Full Text] [Related]
22. The mammalian STE20-like kinase 1 (MST1) is a substrate for the apoptosis inhibiting protein kinase CK2.
Servas C; Kiehlmeier S; Hach J; Gross R; Götz C; Montenarh M
Cell Signal; 2017 Aug; 36():163-175. PubMed ID: 28487119
[TBL] [Abstract][Full Text] [Related]
23. CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells.
Llobet D; Eritja N; Encinas M; Llecha N; Yeramian A; Pallares J; Sorolla A; Gonzalez-Tallada FJ; Matias-Guiu X; Dolcet X
Oncogene; 2008 Apr; 27(18):2513-24. PubMed ID: 17982483
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of CK2 enhances UV-triggered apoptotic cell death in lung cancer cell lines.
Zhao T; Jia H; Li L; Zhang G; Zhao M; Cheng Q; Zheng J; Li D
Oncol Rep; 2013 Jul; 30(1):377-84. PubMed ID: 23595577
[TBL] [Abstract][Full Text] [Related]
25. Impact of protein kinase CK2 on inhibitor of apoptosis proteins in prostate cancer cells.
Wang G; Ahmad KA; Harris NH; Ahmed K
Mol Cell Biochem; 2008 Sep; 316(1-2):91-7. PubMed ID: 18574673
[TBL] [Abstract][Full Text] [Related]
26. Strategies of Targeting CK2 in Drug Discovery: Challenges, Opportunities, and Emerging Prospects.
Chen Y; Wang Y; Wang J; Zhou Z; Cao S; Zhang J
J Med Chem; 2023 Feb; 66(4):2257-2281. PubMed ID: 36745746
[TBL] [Abstract][Full Text] [Related]
27. Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells.
Romieu-Mourez R; Landesman-Bollag E; Seldin DC; Sonenshein GE
Cancer Res; 2002 Nov; 62(22):6770-8. PubMed ID: 12438279
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic targeting of CK2 in acute and chronic leukemias.
Buontempo F; McCubrey JA; Orsini E; Ruzzene M; Cappellini A; Lonetti A; Evangelisti C; Chiarini F; Evangelisti C; Barata JT; Martelli AM
Leukemia; 2018 Jan; 32(1):1-10. PubMed ID: 28951560
[TBL] [Abstract][Full Text] [Related]
29. Alpha B-Crystallin Protects Rat Articular Chondrocytes against Casein Kinase II Inhibition-Induced Apoptosis.
Lee SW; Rho JH; Lee SY; Yoo SH; Kim HY; Chung WT; Yoo YH
PLoS One; 2016; 11(11):e0166450. PubMed ID: 27851782
[TBL] [Abstract][Full Text] [Related]
30. Cellular regulators of protein kinase CK2.
Montenarh M
Cell Tissue Res; 2010 Nov; 342(2):139-46. PubMed ID: 20976471
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and mechanism of anti-tumor action of new potential CK2 inhibitors toward glioblastoma cells.
Kaminska B; Ellert-Miklaszewska A; Oberbek A; Wisniewski P; Kaza B; Makowska M; Bretner M; Kazimierczuk Z
Int J Oncol; 2009 Nov; 35(5):1091-100. PubMed ID: 19787263
[TBL] [Abstract][Full Text] [Related]
32. Targeting CK2 for cancer therapy.
Ahmad KA; Wang G; Slaton J; Unger G; Ahmed K
Anticancer Drugs; 2005 Nov; 16(10):1037-43. PubMed ID: 16222144
[TBL] [Abstract][Full Text] [Related]
33. Protein kinase CK2 - diverse roles in cancer cell biology and therapeutic promise.
Trembley JH; Kren BT; Afzal M; Scaria GA; Klein MA; Ahmed K
Mol Cell Biochem; 2023 Apr; 478(4):899-926. PubMed ID: 36114992
[TBL] [Abstract][Full Text] [Related]
34. The mitochondrial voltage-dependent anion channel 1 in tumor cells.
Shoshan-Barmatz V; Ben-Hail D; Admoni L; Krelin Y; Tripathi SS
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2547-75. PubMed ID: 25448878
[TBL] [Abstract][Full Text] [Related]
35. CK2 signaling in androgen-dependent and -independent prostate cancer.
Wang G; Ahmad KA; Unger G; Slaton JW; Ahmed K
J Cell Biochem; 2006 Oct; 99(2):382-91. PubMed ID: 16598768
[TBL] [Abstract][Full Text] [Related]
36. Induction of cell death in antiestrogen resistant human breast cancer cells by the protein kinase CK2 inhibitor DMAT.
Yde CW; Frogne T; Lykkesfeldt AE; Fichtner I; Issinger OG; Stenvang J
Cancer Lett; 2007 Oct; 256(2):229-37. PubMed ID: 17629615
[TBL] [Abstract][Full Text] [Related]
37. LYG-202 augments tumor necrosis factor-α-induced apoptosis via attenuating casein kinase 2-dependent nuclear factor-κB pathway in HepG2 cells.
Chen FH; Lu N; Zhang HW; Zhao L; He LC; Sun HP; You QD; Li ZY; Guo QL
Mol Pharmacol; 2012 Nov; 82(5):958-71. PubMed ID: 22909797
[TBL] [Abstract][Full Text] [Related]
38. Validation of protein kinase CK2 as oncological target.
Seeber S; Issinger OG; Holm T; Kristensen LP; Guerra B
Apoptosis; 2005 Aug; 10(4):875-85. PubMed ID: 16133877
[TBL] [Abstract][Full Text] [Related]
39. Protein kinase CK2 as regulator of cell survival: implications for cancer therapy.
Unger GM; Davis AT; Slaton JW; Ahmed K
Curr Cancer Drug Targets; 2004 Feb; 4(1):77-84. PubMed ID: 14965269
[TBL] [Abstract][Full Text] [Related]
40. Regulation of the proapoptotic functions of prostate apoptosis response-4 (Par-4) by casein kinase 2 in prostate cancer cells.
de Thonel A; Hazoumé A; Kochin V; Isoniemi K; Jego G; Fourmaux E; Hammann A; Mjahed H; Filhol O; Micheau O; Rocchi P; Mezger V; Eriksson JE; Rangnekar VM; Garrido C
Cell Death Dis; 2014 Jan; 5(1):e1016. PubMed ID: 24457960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
